NCT00221845 Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients Status COMPLETED Phase PHASE3
NCT00191919 A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain Status COMPLETED Phase PHASE3
NCT00191204 Open Label Phase III Duloxetine Study for Stress Urinary Incontinence Status COMPLETED Phase PHASE3
NCT00191087 Duloxetine in the Treatment of Stress Urinary Incontinence. Status COMPLETED Phase PHASE3
NCT00190996 Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence Status COMPLETED Phase PHASE3
NCT00190905 Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions. Status COMPLETED Phase PHASE4
NCT00190866 Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia Syndrome Status COMPLETED Phase PHASE3
NCT00190827 Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine) Status COMPLETED Phase PHASE3
NCT00190814 Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge. Status COMPLETED Phase PHASE3
NCT00190645 To Evaluate the Safety of Duloxetine in Patients With Stress Urinary Incontinence Status COMPLETED Phase PHASE3
NCT00190632 To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary Incontinence Status COMPLETED Phase PHASE3
NCT00190606 Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary Incontinence Status COMPLETED Phase PHASE2
NCT00190567 Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress Incontinence Status COMPLETED Phase PHASE2
NCT00168857 A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study) Status COMPLETED Phase PHASE4
NCT00168818 Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery Status COMPLETED Phase PHASE3
NCT00168805 RE-MODEL Dabigatran Etexilate 150mg or 220mg Once Daily (o.d.) Versus (v.s.) Enoxaparin 40mg o.d. for Prevention of Thrombosis After Knee Surgery Status COMPLETED Phase PHASE3
NCT00168792 A Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early Percutaneous Coronary Intervention (PCI) as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction (ASSENT 4 PCI) Status TERMINATED Phase PHASE4